These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10622069)
1. 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening. Tormey WP; Keeling F; Lee MJ Int J Clin Pract; 1999 Sep; 53(6):428-32. PubMed ID: 10622069 [TBL] [Abstract][Full Text] [Related]
2. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Bhatia KS; Ismail MM; Sahdev A; Rockall AG; Hogarth K; Canizales A; Avril N; Monson JP; Grossman AB; Reznek RH Clin Endocrinol (Oxf); 2008 Aug; 69(2):181-8. PubMed ID: 18394016 [TBL] [Abstract][Full Text] [Related]
3. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651 [TBL] [Abstract][Full Text] [Related]
4. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis. Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578 [TBL] [Abstract][Full Text] [Related]
5. [Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine]. Pucar D; Marković S Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():20-4. PubMed ID: 12584993 [TBL] [Abstract][Full Text] [Related]
7. Intraindividual comparison of 123I-mIBG SPECT/MRI, 123I-mIBG SPECT/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines. Derlin T; Busch JD; Wisotzki C; Schoennagel BP; Bannas P; Papp L; Klutmann S; Habermann CR Clin Nucl Med; 2013 Jan; 38(1):e1-6. PubMed ID: 22996238 [TBL] [Abstract][Full Text] [Related]
8. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618 [TBL] [Abstract][Full Text] [Related]
9. A diagnostic dilemma in diagnosing and managing an incidental phaeochromocytoma. Tahrani AA; Macleod AF Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):204-7. PubMed ID: 16705554 [TBL] [Abstract][Full Text] [Related]
10. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy]. Yokoyama H; Tsuji Y Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357 [TBL] [Abstract][Full Text] [Related]
12. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. Berglund AS; Hulthén UL; Manhem P; Thorsson O; Wollmer P; Törnquist C J Intern Med; 2001 Mar; 249(3):247-51. PubMed ID: 11285044 [TBL] [Abstract][Full Text] [Related]
13. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters]. Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441 [TBL] [Abstract][Full Text] [Related]
14. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma. Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527 [TBL] [Abstract][Full Text] [Related]
15. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma. Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579 [TBL] [Abstract][Full Text] [Related]
16. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma. Greenblatt DY; Shenker Y; Chen H Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324 [TBL] [Abstract][Full Text] [Related]
17. Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma. Newton TD; Augustine T; Arumugam P; Malik RA Clin Nucl Med; 2008 May; 33(5):328-9. PubMed ID: 18431145 [TBL] [Abstract][Full Text] [Related]
18. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032 [TBL] [Abstract][Full Text] [Related]
19. False-positive diagnosis of adrenal phaeochromocytoma on metaiodobenzylguanidine (MIBG) [correction of MIGB] scan. Houghton A; Clarke S; Jourdan M Br J Clin Pract; 1990 Oct; 44(10):411-2. PubMed ID: 2268520 [No Abstract] [Full Text] [Related]
20. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Win Z; Al-Nahhas A; Towey D; Todd JF; Rubello D; Lewington V; Gishen P Nucl Med Commun; 2007 May; 28(5):359-63. PubMed ID: 17414885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]